Search results
Results from the WOW.Com Content Network
Science News Staff News at a glance: Russian brain drain, Trump’s nominees, and a long-distance traveler goes extinct The latest in science and policy
For the first time since 2018, your winner was our winner! This year’s race for the People’s Choice award—an annual honor chosen by Science readers—was tight, with three finalists running neck and neck in the last week of voting on Twitter: ancient soil DNA, CRISPR gene editing in the body, and artificial intelligence–powered protein structure predictions.
Hassabis predicted a “new era in digital biology” in which drug developers could go from AI-predicted structures of proteins important to any medical condition to using AI to design small molecules that influence those proteins—and therefore treat an illness.
Subscribe to News from Science Continue to article Get Science ’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.
The Nobel is “very exciting news for those of us working in the microRNA field,” says Claudio Alonso, a developmental neurobiologist at the University of Sussex who began studying the gene regulators after hearing a talk by Ruvkun in the early 2000s.
This body of work, a cornerstone for the field of quantum biology, rests on the interpretation of small-amplitude oscillations in two-dimensional electronic spectra of photosynthetic complexes. This Review discusses recent work reexamining these claims and demonstrates that interexciton coherences are too short lived to have any functional ...
BIOMEDICINE Big funders to get new leaders. Two of the world’s largest biomedical research sponsors—the U.S. National Institutes of Health (NIH) and the Wellcome Trust—will likely get new directors this year.
As they collect and analyze massive amounts of genetic sequences from plants, animals, and microbes, biologists keep encountering surprises, including some that may challenge the very definition of life.
POLICY The race to regulate AI. Governments around the world last year announced ambitious plans to increase their oversight of artificial intelligence—a race to regulate AI that will likely speed up this year. U.S. agencies face a daunting job to flesh out policy directives announced in November 2023 by President Joe Biden’s administration aimed at setting standards for the responsible ...
“There has been a reckoning,” says Jay Keasling, a synthetic biologist at Lawrence Berkeley National Laboratory and co-founder of Amyris. Still, not all synbio companies are generating bad news, with some focused on pharmaceuticals and additives living up to the hype that has often surrounded the field.